Clinical trial NCT06714487: Cognitive Stimulation in Patients With Sclerosis Multiple
Official title: JUGUEMOS - Cognitive Stimulation Through Games : a New Active Aging Approach to Enhance Users' Everyday Challenges Sclerosis Multiple
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Multiple Sclerosis
Keywords: Multiple sclerosis
play and Playthings
cognitive therapy
Lead sponsor: Institut Investigacio Sanitaria Pere Virgili
Sponsor class: OTHER
First posted: 2024-12-03
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The primary objective of the study is to determine if the training for 6 months with a specific set of games ( previously selected according to the cognitive domain stimulate : attention, memory , executive functions and processing speed ) , so improve significant neuropsychological performance of patients with Multiple Sclerosis Sender Recurrent ( RRMS ) and secondary progressive multiple sclerosis (SPMS ) , your mood and your quality of life.

Design : randomized clinical trial with a control group , coordinated a multicenter sample preselected patients.

Detailed description: A total of 80 patients with RRMS or SPMS, which will be evaluated at baseline were included regarding various clinical, demographic, neuropsychological, psychometric and operational variables.

Subsequently patients will be randomized (in a ratio of 1: 1) to two groups different. The experimental group (EG = 40 patients) participate in a program of stimulation Cognitive group, while the control group (CG = 40 patients) did not receive any experimental intervention. All patients continue to receive drug treatment MS according to the standard treatment algorithms. At 6 months, once patients GE have completed treatment of cognitive stimulation, 80 patients will be reassessed respect to the same variables neuropsychological, psychometric and operation that had It has been evaluated at baseline.

Cognitive differences, clinics and operating both at baseline and at 6 be studied months among patients of GE responders and nonresponders to treatment stimulation cognitive and GC.

Eligibility criteria: Inclusion Criteria:

* Clinical diagnosis of RRMS or SPMS according to Poser criteria (1983) and McDonald (2001).
* Degree of disability between 1 ( clinical signs without disability) and 5.5 (capable of walk 100 meters without aid or rest , disability severe enough to prevent the activities of the whole ) day as the Disability Scale Kurtze (EDSS , 1983).
* Basic treatment for first-line MS ( immunomodulators).
* Complaints cognitive, functional gradation in the scale of dementia GDS ( Global Dementia Staging ) of Reisberg (1982 ) 2 and 4 .
* Patients who have mild to moderate cognitive impairment (have between 20 and 40 % of the altered neuropsychological tests).
* Signed informed consent .

Exclusion Criteria:

* Cognitive impairment associated with other medical diseases (Alzheimer's, stroke, Parkinson's disease, kidney disease, respiratory, hepatic, endocrine or hematological).
* Diagnosis of primary psychiatric disease with cognitive impairment in accordance with DSM-IV-TR criteria: schizophrenia, bipolar disorder, personality...
* Diagnosis or history of substance abuse or dependence.
* Score the Beck Depression Inventory II (BDI-II) greater than or equal to 30.
* Low Intelectual coeficient, inferred through obtaining a scale score less than 4 on the Vocabulary subtest of the WAIS-IV.
* Evidence of delusions, confusion or other disturbances of consciousness.
* Severe sensory deficits (visual and / or auditory)or functional illiteracy in which neuropsychological study can not be carried out.
* Patients treated with immunosuppressive drugs base or second line.
* Patients who are already receiving treatment or have cognitive rehabilitation received in the last 12 months.

Primary outcomes:
measure: Capacity to stimulate the functions cognitive, is why cognitive stimulation through strategies and neuropsychological specific set of board games, improve cognitive performance in patients with RRMS and PMSC .
timeFrame: Cognitive performance baseline (pre intervention) at 6 months (post intervention)
Secondary outcomes:
measure: Positive social interaction generated by the group reinforcement groups treatment will lead to improved mood of its participants.
timeFrame: Social interaction, baseline (pre intervention) at 6 months (post intervention)
measure: Cognitive improvement achieved after participation in a group of cognitive stimulation through strategies and neuropsychological games, improve the quality of life Patients with RRMS and SPMS .
timeFrame: Quality of life (baseline, pre intervention) at 6 months (post intervention)
Other outcomes:
Locations:
Study officials:
References: